Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers N > Headlines for Noven Pharmaceuticals Inc. > News item |
Noven maintained by Jefferies at buy
Noven Pharmaceuticals Inc. was maintained by Jefferies & Co. analyst David Windley at a buy rating with a price target on the stock of $20 per share following second-quarter results Noven shares Friday were up $0.37, or 2.11%, at $17.89 on volume of 201,958 shares versus the three-month running average of 162,795 shares.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.